Trial site
Icahn School of Medicine at Mt. Sinai
- 12running trials
- 5closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer3 trials
- Colorectal cancer3 trials
- Multiple myeloma3 trials
- Head and neck cancer2 trials
- HIV2 trials
- Lung cancer2 trials
- Pancreatic cancer2 trials
- Type 2 diabetes2 trials
- Acute myeloid leukaemia1 trial
- Amyloidosis1 trial
- Atrial fibrillation1 trial
- Cervical cancer1 trial
- and 14 more
- Phase
- Phase 14 trials
- Phase 33 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Recruiting6 trials
- Active, not recruiting5 trials
- Completed4 trials
- Enrolling by invitation1 trial
- Withdrawn1 trial
- Lead sponsor
- Janssen Research & Development, LLC4 trials
- MacroGenics2 trials
- Tandem Diabetes Care, Inc.2 trials
- Abiomed Inc.1 trial
- Agios Pharmaceuticals, Inc.1 trial
- and 7 more
Running trials
Recruiting
Active, not recruiting
Recruiting
A Study of MGC028 in Participants With Advanced Solid Tumors
Recruiting
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma3 recruiting
- Colorectal cancer2 recruiting
- Acute myeloid leukaemia1 recruiting
- Amyloidosis1 recruiting
- Bladder cancer1 recruiting
- Follicular lymphoma1 recruiting
- Head and neck cancer1 recruiting
- HIV1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Pancreatic cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Withdrawn
Completed
Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes
Completed
A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes
Completed
Completed
A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy
Site data: ClinicalTrials.govUpdated 18 Nov 2026